3-Aminohexanoic acid, 97%, 250mg

N-(2-Aminoethyl)-2-(naphthalen-1-yl)acetamide, 95%, 100mg

2-(2-((4-Methoxyphenoxy)methyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 250mg

2-(2-Chloro-acetylamino)-4-(2-chloro-phenyl)-thiophene-3-carboxylic acid ethyl ester, 95.0%, 1g

3-Chloro-2-methylbenzylamine, 95.0%, 50mg

(R)-6-bromo-1-(sec-butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-1H-indole-4-carboxamide, 95%, 500mg

3-Bromoimidazo[5,1-b]thiazole-7-carboxylic acid, 95%, 100mg

Dihydrothiophen-3(2H)-one, 95.0%, 100g

16-Bromo-1-hexadecanol, 95.0%, 5g

(2E)-3-(2-chlorophenyl)-1-(4-methoxyphenyl)prop-2-en-1-one, 95.0%, 2g

Dialysis systems Spectra/Por® Float-A-Lyzer® G2 Filling volume 1 ml, 100–500 dalton(s), 12 Piece(s)

ethyl 5-oxo-1-(propan-2-yl)-2,5-dihydro-1H-pyrazole-3-carboxylate, 95+%, 1g

CYCLOPENTADIENYL MANGANESE TRICARBONYL, 95.0%, 250mg